Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

COVID-19

Free Subscription 22.04.2024 1 Am J Respir Crit Care Med 4 Ann Intern Med 2 BMJ 1 Clin Infect Dis 1 Infect Control Hosp Epidemiol 8 Int J Infect Dis 1 J Infect 8 J Med Virol 1 J Travel Med 6 J Virol 2 Lancet Infect Dis 2 MMWR Morb Mortal Wkly Rep 3 Nature 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Crit Care Med

1. ATRAMONT A, Martin GL, Singer M, Tajahmady A, et al
   One-Year Survival and Hospital-free Days in Critical Illness After Viral Pneumonia.
   Am J Respir Crit Care Med. 2024;209:1019-1022.
   PubMed        
   
   

   
   Ann Intern Med

2. WEITZ HH, Merli GJ
   Annals Consult Guys - COVID-19 and Surgery: A Postpandemic Update.
   Ann Intern Med. 2024;177:eW240001.
   PubMed        
   
   
3. ALHAMMADI A, Alshawaf R, Chavda S, Ramondino S, et al
   Infectious Diseases: What You May Have Missed in 2023.
   Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0679.
   PubMed         Abstract available
   
   
4. COSCHI CH, Dodbiba L, Guerry D
   Oncology: What You May Have Missed in 2023.
   Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
   PubMed         Abstract available
   
   
5. ALHABOBI AAM, Almutairi AMS, Bohemid DASY, Sehgal AR, et al
   Nephrology: What You May Have Missed in 2023.
   Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0605.
   PubMed         Abstract available
   
   

   
   BMJ

6. COLLINS GS, Moons KGM, Dhiman P, Riley RD, et al
   TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.
   BMJ. 2024;385:e078378.
   PubMed         Abstract available
   
   
7. MAHASE E
   Covid-19: Charities question inquiry's "refusal" to fully examine mental health impact.
   BMJ. 2024;385:q852.
   PubMed        
   
   

   
   Clin Infect Dis

8. 
   Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
   Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
   PubMed        
   
   

   
   Infect Control Hosp Epidemiol

9. BUCHANAN MO, Sickbert-Bennett EE, Selimos A, Dean SM, et al
   Strategies to maintain an N95 respirator supply during a pandemic supply-chain shortage.
   Infect Control Hosp Epidemiol. 2024;45:688-689.
   PubMed        
   
   

   
   Int J Infect Dis

10. SLURINK IAL, van den Houdt SCM, Mertens G
    Who develops long COVID? Longitudinal pre-pandemic predictors of long COVID and symptom clusters in a representative Dutch population.
    Int J Infect Dis. 2024 Apr 10:107048. doi: 10.1016/j.ijid.2024.107048.
    PubMed         Abstract available
    
    
11. VERGORI A, Lepri AC, Chiuchiarelli M, Mazzotta V, et al
    Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
    Int J Infect Dis. 2024 Apr 11:107042. doi: 10.1016/j.ijid.2024.107042.
    PubMed         Abstract available
    
    
12. CHEN H, Yu L, Wang L, Zhang J, et al
    Demographic characteristics and risk factors for invasive fungal sinusitis in the context of COVID-19: A systematic review and meta-analysis.
    Int J Infect Dis. 2024 Apr 11:107054. doi: 10.1016/j.ijid.2024.107054.
    PubMed         Abstract available
    
    
13. LIEW YX, Ho AYL, Wong GC, Chung SJ, et al
    A retrospective study of intravenous pentamidine for PCP prophylaxis in adult patients with hematological malignancies - its utility during respiratory virus pandemics.
    Int J Infect Dis. 2024 Apr 12:107059. doi: 10.1016/j.ijid.2024.107059.
    PubMed         Abstract available
    
    
14. GRONING R, Walde J, Ahlm C, Forsell MN, et al
    Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study.
    Int J Infect Dis. 2024 Apr 12:107046. doi: 10.1016/j.ijid.2024.107046.
    PubMed         Abstract available
    
    
15. GLASER N, Diexer S, Klee B, Purschke DO, et al
    The contribution of SARS-CoV-2 to the burden of acute respiratory infections in winter season 2022/2023: Results from the DigiHero study.
    Int J Infect Dis. 2024 Apr 15:107057. doi: 10.1016/j.ijid.2024.107057.
    PubMed         Abstract available
    
    
16. RICCIO MD, Caini S, Bonaccorsi G, Lorini C, et al
    Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS).
    Int J Infect Dis. 2024 Apr 16:107052. doi: 10.1016/j.ijid.2024.107052.
    PubMed         Abstract available
    
    
17. GRIFFITHS M, Hatabah D, Sullivan P, Mantus G, et al
    Incidence of SARS-CoV-2 Seropositivity in Pediatric Healthcare Workers Prior to Widespread Vaccination: A Five-month Longitudinal Cohort Study.
    Int J Infect Dis. 2024 Apr 17:107064. doi: 10.1016/j.ijid.2024.107064.
    PubMed         Abstract available
    
    

    
    J Infect

18. CHUN JY, Jeong SJ, Kim S, Choi S, et al
    Performance of the Galactomannan Test for the Diagnosis of Invasive Pulmonary Aspergillosis using Non-invasive Proximal Airway Samples.
    J Infect. 2024 Apr 17:106159. doi: 10.1016/j.jinf.2024.106159.
    PubMed         Abstract available
    
    

    
    J Med Virol

19. MENG H, Wang Y, Zhai Y, Luo W, et al
    Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults.
    J Med Virol. 2024;96:e29611.
    PubMed         Abstract available
    
    
20. MAHLA RS, Dustin LB
    COVID-19 vaccination and autoimmunity: Do we need more evidence?
    J Med Virol. 2024;96:e29623.
    PubMed        
    
    
21. WEI M, Li S, Lu X, Hu K, et al
    Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China.
    J Med Virol. 2024;96:e29616.
    PubMed         Abstract available
    
    
22. OKITSU S, Khamrin P, Hikita T, Onda Y, et al
    Remarkable increase in the detection and molecular characterization of adenovirus F41 in children with acute gastroenteritis in Japan, 2017-2023.
    J Med Virol. 2024;96:e29615.
    PubMed         Abstract available
    
    
23. MATUSALI G, Vergori A, Cimini E, Mariotti D, et al
    Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
    J Med Virol. 2024;96:e29598.
    PubMed         Abstract available
    
    
24. CHEN IW, Weng HL, Lai YC, Hung KC, et al
    Incidence of fatigue 2 years after SARS-CoV-2 infection: An updated meta-analysis and subgroup analysis.
    J Med Virol. 2024;96:e29619.
    PubMed        
    
    
25. DESTREMAU M, Chaussade H, Hemar V, Beguet M, et al
    Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study.
    J Med Virol. 2024;96:e29603.
    PubMed         Abstract available
    
    
26. SUN Q, Gao J, An R, Wang M, et al
    Probing molecular pathways: Illuminating the connection between COVID-19 and Alzheimer's disease through the endocannabinoid system dynamics.
    J Med Virol. 2024;96:e29590.
    PubMed         Abstract available
    
    

    
    J Travel Med

27. WARDLE J, Bhatia S, Cori A, Nouvellet P, et al
    Temporal variations in international air travel: implications for modelling the spread of infectious diseases.
    J Travel Med. 2024 Mar 17:taae062. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

28. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    PubMed         Abstract available
    
    
29. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    PubMed         Abstract available
    
    
30. EBRIGHT RH, MacIntyre R, Dudley JP, Butler CD, et al
    Implementing governmental oversight of enhanced potential pandemic pathogen research.
    J Virol. 2024;98:e0023724.
    PubMed        
    
    
31. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    PubMed         Abstract available
    
    
32. WANG X, Qiu W, Hu G, Diao X, et al
    NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production.
    J Virol. 2024 Apr 16:e0031724. doi: 10.1128/jvi.00317.
    PubMed         Abstract available
    
    
33. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

34. 
    Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet Infect Dis. 2024 Apr 16:S1473-3099(24)00158.
    PubMed         Abstract available
    
    
35. 
    Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
    Lancet Infect Dis. 2024 Apr 15:S1473-3099(24)00176.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

36. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    PubMed         Abstract available
    
    
37. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    PubMed         Abstract available
    
    

    
    Nature

38. DOLGIN E
    mRNA drug offers hope for treating a devastating childhood disease.
    Nature. 2024;628:248.
    PubMed        
    
    
39. KOZLOV M
    US COVID-origins hearing puts scientific journals in the hot seat.
    Nature. 2024 Apr 16. doi: 10.1038/d41586-024-01129.
    PubMed        
    
    
40. LADYZHETS B
    What toilets can reveal about COVID, cancer and other health threats.
    Nature. 2024;628:492-494.
    PubMed        
    
    

    
    Science

41. COUZIN-FRANKEL J
    Lessons in persistence.
    Science. 2024;384:150-154.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.